REG - Spire Healthcare Grp - Notice of Interim Results

Spire HealthcareAnnouncement

15/08/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240815:nRSO4850Aa&default-theme=true

RNS Number : 4850A  Spire Healthcare Group PLC  15 August 2024

Spire Healthcare Group plc

 

('Spire Healthcare', 'the Company' or 'the Group')

 

Notice of Interim Results

 

15 August 2024

 

Spire Healthcare Group plc (LSE: SPI), a leading independent healthcare group
in the United Kingdom, will announce its interim results for the six months
ended 30 June 2024 on Thursday, 12 September 2024.

 

A presentation for sell-side analysts and institutional investors will be held
on the day of the interim results announcement at 9.00am (BST) at the offices
of Instinctif Partners, 65 Gresham Street, London, EC2V 7NQ. Refreshments will
be available from 8.30am (BST). If you wish to attend the presentation, please
contact Instinctif Partners at spire@instinctif.com
(mailto:spire@instinctif.com) .

 

Following the presentation, there will be a moderated Q&A session.

 

For those who cannot attend in person, the presentation will also be
accessible via live Zoom webcast.

 

Click the following link to register in advance for the Zoom webcast and to
receive access details:

https://spirehealthcare.zoom.us/webinar/register/WN_lnWbJHGcQs2BHYE8b9lcTA
(https://spirehealthcare.zoom.us/webinar/register/WN_lnWbJHGcQs2BHYE8b9lcTA)

 

A recording of the webcast will be made available from 1.00pm (BST) on 12
September on the Spire Healthcare website,
https://www.investors.spirehealthcare.com
(https://www.investors.spirehealthcare.com)

 

- Ends -

 

For further information please contact:

 

 Spire Healthcare

 Angus Prentice - Director of Investor Relations   +44 (0)7974 982 512

 Instinctif Partners

 Julian Walker                                     +44 (0)7825 189 696

 Guy Scarborough                                   +44 (0)7917 178 920

 

Registered Office and Head Office:

 

Spire Healthcare Group plc

3 Dorset Rise

London

EC4Y 8EN

Registered number 09084066

 

About Spire Healthcare

 

Spire Healthcare (http://www.spirehealthcare.com/) is a leading independent
healthcare group in the United Kingdom, running 39 hospitals and over 50
clinics, medical centres and consulting rooms across England, Wales and
Scotland. It operates a network of private GPs and provides occupational
health services to over 800 corporate clients.

 

Working in partnership with over 8,600 experienced consultants, Spire
Healthcare delivered tailored, personalised care to over 1 million inpatients,
outpatients and daycase patients, and occupational health programme clients,
in 2023, and is the leading private provider, by volume, of knee
(https://www.spirehealthcare.com/treatments/bones-and-joints/knee-replacement/)
and hip
(https://www.spirehealthcare.com/treatments/bones-and-joints/hip-replacement-surgery/)
operations in the United Kingdom. It also delivers a range of private and NHS
mental health, musculoskeletal and dermatological services under the Vita
Health Group brand.

 

Spire Healthcare's well-located and scalable hospitals have delivered
successful and award-winning outcomes, positioning the group well with
patients, consultants, the NHS, GPs and Private Medical Insurance ('PMI')
providers. 98% of Spire Healthcare's inspected locations are rated 'Good',
'Outstanding' or the equivalent by health inspectors in England, Wales and
Scotland.

 

Spire Healthcare is listed on the London Stock Exchange and is a member of the
FTSE 250.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NORZZLFFZVLEBBF